NCT00109239View on ClinicalTrials.gov

A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2000

Study Completion Date

September 30, 2002

Conditions
Breast Cancer
Interventions
DRUG

rhuMAb VEGF (Bevacizumab)

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY